Russell Investments Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.67K | Sell |
2,905
-2,742
| -49% | -$7.24K | ﹤0.01% | 3379 |
|
|
2025
Q1 | $17K | Buy |
5,647
+2,349
| +71% | +$7.07K | ﹤0.01% | 3140 |
|
|
2024
Q4 | $8.44K | Sell |
3,298
-6,318
| -66% | -$16.2K | ﹤0.01% | 3176 |
|
|
2024
Q3 | $35.8K | Buy |
9,616
+1,199
| +14% | +$4.46K | ﹤0.01% | 2846 |
|
|
2024
Q2 | $53.2K | Buy |
8,417
+5,512
| +190% | +$34.8K | ﹤0.01% | 2750 |
|
|
2024
Q1 | $15.6K | Sell |
2,905
-11,861
| -80% | -$63.7K | ﹤0.01% | 2801 |
|
|
2023
Q4 | $74.1K | Buy |
14,766
+11,861
| +408% | +$59.5K | ﹤0.01% | 2598 |
|
|
2023
Q3 | $4.91K | Hold |
2,905
| – | – | ﹤0.01% | 3146 |
|
|
2023
Q2 | $8.08K | Hold |
2,905
| – | – | ﹤0.01% | 3009 |
|
|
2023
Q1 | $5.29K | Buy |
+2,905
| New | +$5.29K | ﹤0.01% | 2941 |
|
|
2022
Q1 | – | Sell |
-113,723
| Closed | -$691K | – | 2837 |
|
|
2021
Q4 | $691K | Buy |
113,723
+32,502
| +40% | +$197K | ﹤0.01% | 2323 |
|
|
2021
Q3 | $791K | Buy |
81,221
+78,738
| +3,171% | +$767K | ﹤0.01% | 2286 |
|
|
2021
Q2 | $35K | Sell |
2,483
-138,119
| -98% | -$1.95M | ﹤0.01% | 3157 |
|
|
2021
Q1 | $3.34M | Sell |
140,602
-40,091
| -22% | -$951K | 0.01% | 1571 |
|
|
2020
Q4 | $2.41M | Buy |
180,693
+73,812
| +69% | +$986K | ﹤0.01% | 1655 |
|
|
2020
Q3 | $741K | Buy |
+106,881
| New | +$741K | ﹤0.01% | 2209 |
|
|
2018
Q4 | – | Sell |
-17,100
| Closed | -$63K | – | 2971 |
|
|
2018
Q3 | $63K | Sell |
17,100
-700
| -4% | -$2.58K | ﹤0.01% | 2810 |
|
|
2018
Q2 | $54K | Buy |
+17,800
| New | +$54K | ﹤0.01% | 2801 |
|
|
2017
Q4 | – | Sell |
-25,320
| Closed | -$139K | – | 2976 |
|
|
2017
Q3 | $139K | Buy |
+25,320
| New | +$139K | ﹤0.01% | 2731 |
|
|
2017
Q2 | – | Sell |
-21,330
| Closed | -$76K | – | 2990 |
|
|
2017
Q1 | $76K | Buy |
+21,330
| New | +$76K | ﹤0.01% | 2851 |
|